Grant: CIHR Fellowship
University of Ottawa
$55,000.00
Clinical decision-making and HIV Pre-Exposure Prophylaxis (PrEP): Examining clinician and user perspectives
EF 2014-15
Résumé
This project seeks to examine the recent emergence of HIV Pre-Exposure Prophylaxis (PrEP) for men who have sex with men (MSM). PrEP involves taking a single dose of the same medication that people living with HIV use, but to prevent infection. Currently, PrEP is not widely available in Canada, but some physicians are already prescribing it to MSM. Clinical trials have shown that PrEP could dramatically reduce the cases of new HIV infections if taken correctly. However, there remain many questions that still need to be answered about how PrEP will be used in practice. This project will use interviews conducted in major cities in Canada to collect the experiences of clinicians (e,g., physicians, nurses, and social workers) and diverse groups of MSM about PrEP related clinical encounters, and what they see as the opportunities and challenges presented by this new HIV prevention approach. This project has implications for improving clinical guidelines and MSM targeted programing.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
318878
Name
Guta Adrian
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Allied Health Professionals - Fellowships
Projecttitle
Clinical decision-making and HIV Pre-Exposure Prophylaxis (PrEP): Examining clinician and user perspectives
Programtype2
Fellowship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$55,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Hiv Prevention; Hiv/Aids; Men Who Have Sex With Men (Msm); Public Health; Qualitative; Social Science
Abstract
This project seeks to examine the recent emergence of HIV Pre-Exposure Prophylaxis (PrEP) for men who have sex with men (MSM). PrEP involves taking a single dose of the same medication that people living with HIV use, but to prevent infection. Currently, PrEP is not widely available in Canada, but some physicians are already prescribing it to MSM. Clinical trials have shown that PrEP could dramatically reduce the cases of new HIV infections if taken correctly. However, there remain many questions that still need to be answered about how PrEP will be used in practice. This project will use interviews conducted in major cities in Canada to collect the experiences of clinicians (e,g., physicians, nurses, and social workers) and diverse groups of MSM about PrEP related clinical encounters, and what they see as the opportunities and challenges presented by this new HIV prevention approach. This project has implications for improving clinical guidelines and MSM targeted programing.
Competitiondate
201411
Approvedterm2
1 yr 0 mth
Pinamesdelim
Guta, Adrian
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $55,000~ $0~